PUBLISHER: IMARC | PRODUCT CODE: 1722561
PUBLISHER: IMARC | PRODUCT CODE: 1722561
The global mother and child healthcare market size reached USD 904.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2,427.8 Billion by 2033, exhibiting a growth rate (CAGR) of 11.01% during 2025-2033. The market is driven by the growing adoption of digital health solutions, as they improve accessibility, efficiency, and patient engagement, increasing healthcare spending, which plays a vital role in advancing maternal and child healthcare by enhancing access and quality of healthcare services, and rising reliance on healthcare insurance coverage.
Mother and child healthcare (MCH) refers to medical services provided to children, adolescents and pregnant women. It includes birthing, fertility, child nutrition, prenatal and postnatal services. MCH emphasizes on preventive, curative, promotive and rehabilitative healthcare services that assist in promoting health, child nutrition and preventing medical ailments to reduce infant and maternal mortality. MCH aids in reducing morbidity and mortality due to unsafe abortions, levels of unwanted and unplanned pregnancies, female genital mutilation, risks of developing cervical cancer and enhancing reproductive health awareness among children. MCH also prevents malnutrition and infection among mothers and children and provides primary health care services.
Significant growth in the healthcare industry is one of the key factors creating a positive outlook for the market. MCH is widely adopted by parents to seek consultation from super-specialist doctors and ensure the good health of both mother and child. Additionally, the widespread adoption of MCH services by pregnant women due to insufficient or no availability of prenatal care and delivery without assistance from appropriately trained health care providers is favoring the market growth. Moreover, the development of various nutritional and micronutrient supplementation strategies that include zinc, calcium, iron and early prenatal food supplementation is providing a thrust to the market growth. These supplements provide essential nutrients in the required quantities and protect the mother and child from infections and diseases. In line with this, the easy availability of digitized claim processing and healthcare policy management solutions is positively impacting the market growth. Other factors, including the increasing number of women suffering from immunodeficiency virus and other chronic illnesses, along with the implementation of various government initiatives to improve public health, are anticipated to drive the market toward growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ann & Robert Lurie Children's Hospital, Apollo Hospitals Enterprise Ltd., Arrowhead Regional Medical Center, Carle Foundation Hospital, ChristianaCare Christiana Hospital, Cincinnati Children's Hospital, Cleveland Clinic Institute, Cloudnine Group of Hospitals, King Faisal Specialist Hospital & Research Centre, Riley Hospital and The Jorvi Hospital.